Rodriguez C, Diswall M, Olsson A, Jonsson T, Johansson E, Blomqvist M
JIMD Rep. 2024; 65(6):442-449.
PMID: 39512435
PMC: 11540561.
DOI: 10.1002/jmd2.12448.
Costi S, Caporali R, Marino A
Diagnostics (Basel). 2023; 13(1).
PMID: 36611367
PMC: 9818175.
DOI: 10.3390/diagnostics13010075.
Voskoboeva E, Bookina T, Semyachkina A, Mikhaylova S, Vashakmadze N, Baydakova G
Front Mol Biosci. 2022; 8:783644.
PMID: 35141277
PMC: 8819008.
DOI: 10.3389/fmolb.2021.783644.
Goldman E, Vu A, Dietz K, Thomas S
Clin Med Insights Case Rep. 2021; 14:1179547621999409.
PMID: 33746520
PMC: 7940721.
DOI: 10.1177/1179547621999409.
Chkioua L, Grissa O, Leban N, Gribaa M, Boudabous H, Turkia H
BMC Med Genet. 2020; 21(1):111.
PMID: 32448126
PMC: 7247178.
DOI: 10.1186/s12881-020-01051-9.
Biomarkers for Lysosomal Storage Disorders with an Emphasis on Mass Spectrometry.
Mashima R, Okuyama T, Ohira M
Int J Mol Sci. 2020; 21(8).
PMID: 32295281
PMC: 7215887.
DOI: 10.3390/ijms21082704.
Advances in glycosaminoglycan detection.
Khan S, Mason R, Kobayashi H, Yamaguchi S, Tomatsu S
Mol Genet Metab. 2020; 130(2):101-109.
PMID: 32247585
PMC: 7198342.
DOI: 10.1016/j.ymgme.2020.03.004.
Mucopolysaccharidosis Type I.
Kubaski F, de Oliveira Poswar F, Michelin-Tirelli K, Matte U, Horovitz D, Barth A
Diagnostics (Basel). 2020; 10(3).
PMID: 32188113
PMC: 7151028.
DOI: 10.3390/diagnostics10030161.
Novel splice site IDUA gene mutation in Tunisian pedigrees with hurler syndrome.
Chkioua L, Boudabous H, Jaballi I, Grissa O, Ben Turkia H, Tebib N
Diagn Pathol. 2018; 13(1):35.
PMID: 29843745
PMC: 5975427.
DOI: 10.1186/s13000-018-0710-3.
Glycosaminoglycans detection methods: Applications of mass spectrometry.
Kubaski F, Osago H, Mason R, Yamaguchi S, Kobayashi H, Tsuchiya M
Mol Genet Metab. 2016; 120(1-2):67-77.
PMID: 27746032
PMC: 5477676.
DOI: 10.1016/j.ymgme.2016.09.005.
Molecular analysis in a GALNS study cohort of 15 Tunisian patients: description of a novel mutation.
Chkioua L, Khedhiri S, Hafsi H, Grissa O, Ben Turkia H, Miled A
Diagn Pathol. 2016; 11(1):51.
PMID: 27317439
PMC: 4912732.
DOI: 10.1186/s13000-016-0498-y.
Mental retardation in mucopolysaccharidoses correlates with high molecular weight urinary heparan sulphate derived glucosamine.
Coppa G, Gabrielli O, Zampini L, Maccari F, Mantovani V, Galeazzi T
Metab Brain Dis. 2015; 30(6):1343-8.
PMID: 26016623
DOI: 10.1007/s11011-015-9684-y.
FACE analysis as a fast and reliable methodology to monitor the sulfation and total amount of chondroitin sulfate in biological samples of clinical importance.
Karousou E, Asimakopoulou A, Monti L, Zafeiropoulou V, Afratis N, Gartaganis P
Molecules. 2014; 19(6):7959-80.
PMID: 24927366
PMC: 6271866.
DOI: 10.3390/molecules19067959.
Clinical manifestations in female carriers of mucopolysaccharidosis type II: a Spanish cross-sectional study.
Guillen-Navarro E, Domingo-Jimenez M, Alcalde-Martin C, Cancho-Candela R, Couce M, Galan-Gomez E
Orphanet J Rare Dis. 2013; 8:92.
PMID: 23800320
PMC: 3697996.
DOI: 10.1186/1750-1172-8-92.
Spondyloepiphyseal dysplasias and bilateral legg-calvé-perthes disease: diagnostic considerations for mucopolysaccharidoses.
Mendelsohn N, Wood T, Olson R, Temme R, Hale S, Zhang H
JIMD Rep. 2013; 11:125-32.
PMID: 23657977
PMC: 3755551.
DOI: 10.1007/8904_2013_231.
Sanfilippo syndrome: a mini-review.
Valstar M, Ruijter G, van Diggelen O, Poorthuis B, Wijburg F
J Inherit Metab Dis. 2008; 31(2):240-52.
PMID: 18392742
DOI: 10.1007/s10545-008-0838-5.
